The BIO International Convention (BIO) takes place from June 3rd to 6th in Philadelphia, Pennsylvania. More than 16,000 companies from the biotechnology and pharma industries will be meeting for intensive networking and to discover exciting new possibilities.
The BIO offers a wide range of exhibitors from life-science and other fields like drug discovery and development, bio processing, genomics, biofuels, nanotechnology and cell therapy.
Single Use Support will be one of the exhibitors and we will present and discuss our newest developments and biopharma technologies. Our special field is the handling of biopharma logistics processes based on single use bags.
In order to make this process 100% safe and efficient, we continuously develop new technologies that are compatible with single use bags from any established manufacturer. This allows for endless scalability and lets you handle the entire process from the lab to high-volume production with one single technology.
Our technology includes Freeze/Thaw platforms for the rapid freezing of bulk substances, be it in small batches or blockbuster volumes. Furthermore, it encompasses a fully automated integrity test that tests single use bags for microscopically small holes, thus preventing the infiltration with bacteria. Our developments reduce the risk of “loss of drug substance” towards 0 and push patient safety to the next level.
Come and visit us at the BIO Convention in Philadelphia to discuss technologies and options for your company and how to make your processes even more efficient with our products. You will find us at booth #437:
You can also sign up for the MyBIO Planning Tool on. You will then receive personalized information regarding sessions, events, speakers and exhibitors at the BIO 2019.
The BIO One-on-One Partnering™ Tool furthermore allows you to organize and schedule personal meetings. This is an efficient way of doing business in the biotech and pharma industry and you won’t have to travel the globe to do so. Our system allows you to find and identify potential partners and request meetings with potential biotech investors and business development executives.